Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
43.99
+0.00 (+0.01%)
Streaming Delayed Price
Updated: 1:22 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Karuna Stock Soars On Bristol Myers' $14 Billion Takeover
December 22, 2023
Karuna is working on treatments for schizophrenia and Alzheimer's disease psychosis.
Via
Investor's Business Daily
3 Potential Turnaround Stocks to Buy for Big Rewards in 2024
December 20, 2023
There was plenty to get excited about in 2023 and even more to get excited about with turnaround stocks in the new year.
Via
InvestorPlace
Better Dividend Stock: Bristol Myers Squibb or Merck?
December 19, 2023
These two pharma stocks have sizable dividend yields. Which is the better buy right now?
Via
The Motley Fool
Jim Cramer Slams FTC Chair Lina Khan's Policies For Hampering Investor Returns: 'One-Woman Wrecking Crew For Your Stock Portfolio'
December 18, 2023
He posits that such actions have negatively impacted stock valuations.
Via
Benzinga
7 Stocks with Strong Insider Buying: December 2023
December 17, 2023
Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024.
Via
InvestorPlace
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
December 15, 2023
Via
Benzinga
Is Bristol Myers Squibb Stock a Buy Now?
December 15, 2023
The answer might depend on the kind of investor you are.
Via
The Motley Fool
Is NYSE:BMY a Good Fit for Dividend Investing?
December 14, 2023
Balancing Dividends and Fundamentals: The Case of BRISTOL-MYERS SQUIBB CO (NYSE:BMY).
Via
Chartmill
Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal
December 16, 2023
SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement.
Via
Talk Markets
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)
Via
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Regulators are already on the case, and their findings will have financial impacts.
Via
The Motley Fool
3 Dividend Stocks Trading at 52-Week Lows
December 09, 2023
All three of these companies have seen brighter days.
Via
The Motley Fool
Insiders Buying Bristol-Myers Squibb And 3 Other Stocks
December 08, 2023
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Bristol-Myers Squibb Unusual Options Activity
November 27, 2023
Via
Benzinga
Exploring NYSE:BMY's dividend characteristics.
November 22, 2023
Why BRISTOL-MYERS SQUIBB CO (NYSE:BMY) qualifies as a good dividend investing stock.
Via
Chartmill
Looking Into Bristol-Myers Squibb's Recent Short Interest
November 21, 2023
Via
Benzinga
Why Bristol Myers Squibb's Shares Are Gaining Today?
December 07, 2023
Bristol Myers Squibb & Co (NYSE: BMY) released topline data from Phase 3 CheckMate -8HW trial of Opdivo (nivolumab) plus Yervoy (ipilimumab) compared to the investigator’s choice of chemotherapy as a...
Via
Benzinga
Pharma Industry on Alert as Biden Administration Explores Patent Seizure Powers
December 07, 2023
The White House is endorsing a contentious power that permits the government to reclaim patents for specific
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
December 06, 2023
Investors hunt for new opportunities in stocks that have been discounted & now present promising options for recovery.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Dirt-Cheap Stocks That Could Skyrocket
December 05, 2023
Low valuations don't always guarantee gains are in the offing. You need a company firing on all cylinders, too.
Via
The Motley Fool
Can Bristol Myers Squibb Keep Its Streak Alive?
November 29, 2023
Bristol Myers Squibb is a $100 billion market cap pharmaceutical company that has raised its dividend every year since 2010 and has paid one since 1933.
Via
Talk Markets
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tuesday, the FDA said it received reports of patients developing T-cell malig
Via
Benzinga
Exposures
Product Safety
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
November 28, 2023
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb.
Via
InvestorPlace
Why Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today?
November 28, 2023
Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NYSE: BMY) focused on discovering, developing, and commercializing multiple...
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
November 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
November 26, 2023
These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life.
Via
InvestorPlace
Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale
November 24, 2023
Sometimes the stock market offers its own version of Black Friday deals.
Via
The Motley Fool
$1M Bet On Iridium Communications? Check Out These 3 Stocks Insiders Are Buying
November 22, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Soothing Stocks: 7 Reliable Picks to Ease Your Market Jitters
November 20, 2023
While circumstances may seem relatively normal now, astute investors may want to consider reliable stocks just in case.
Via
InvestorPlace
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
November 20, 2023
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF)
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.